Status:
COMPLETED
Effects of Transcutaneous Vagus Nerve Stimulation (taVNS) in Individuals With Primary Dysmenorrhea
Lead Sponsor:
Artvin Coruh University
Conditions:
Dysmenorrhea Primary
Pain
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study aims to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on pain, functional and emotional symptoms, and physical performance in individuals with primary ...
Detailed Description
In this study, which will be conducted over two menstrual cycles, 34 patients with PD will be randomised into two groups: taVNS and sham treatment. From the onset of pain during the menstrual cycle, t...
Eligibility Criteria
Inclusion
- Being diagnosed with PD according to the No. 345 Primary Dysmenorrhea Consensus Guidelines,
- An NRS score of at least three during menstruation before treatment,
- Being a woman between the ages of 18-40,
- A regular menstrual cycle of 28±7 days,
- Being nulliparous,
- No history of brain surgery, tumour or intracranial metal implantation,
- No chronic genitourinary infection or alcohol or drug use.
Exclusion
- History of dizziness or epileptic disease,
- Pregnancy,
- Women with intrauterine devices,
- Metal implants in the head area,
- Women with skin lesions in the area where the electrodes will be placed,
- Use of analgesic drugs during treatment,
- Women with neurological or heart disease,
- Women are diagnosed with gynaecological conditions (endometriosis, adenomyosis, uterine fibroids, etc., which may be associated with secondary dysmenorrhea).
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06146569
Start Date
November 15 2023
End Date
January 30 2024
Last Update
October 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zeynep Yıldız Kızkın
Artvin, Turkey (Türkiye), 08000